Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02679131
Title To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Spectrum Pharmaceuticals, Inc
Age Groups: adult
Covered Countries USA

No variant requirements are available.